Feeding and reward interactions from chronic paroxetine treatment

Pharmacology Biochemistry and Behavior

Volumn 63, Issue 3, 1999, Pages 435-440

  Konkle, Anne T M ^a   Bielajew, Catherine ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Antidepressants; Brain stimulation reward; Feeding; Medial forebrain bundle; Paroxetine; SSRI; Weight

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FACILITATION; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEDIAL FOREBRAIN BUNDLE; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRODES, IMPLANTED; FEEDING BEHAVIOR; MALE; MEDIAL FOREBRAIN BUNDLE; PAROXETINE; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; REWARD; SEROTONIN UPTAKE INHIBITORS; STEREOTAXIC TECHNIQUES;

EID: 0032997079     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00044-1     Document Type: Article

References (44)

1. Adler L.A., Angrist B.M. Paroxetine and akathisia. Biol. Psychiatry. 37:1995;336-337.
2. Aranth J.A., Lindberg C. Bleeding, a side effect of fluoxetine. Am. J. Psychiatry. 149:1992;412.
3. Artigas F., Bel N., Casanovas J.M., Romero L. Adaptive changes of the serotonergic system after antidepressant treatments. Filippini G.A., Costa C.V., Bertazzo A. Recent advances in tryptophan research. 1996;51-59 Plenum Press, New York.
4. Barr L.C., Heninger G.R., Goodman W., Charney D.S., Price L.H. Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects. Biol. Psychiatry. 41:1997;949-954.
5. Binks S.M., Murchie J.K., Greenwood D.T. A reward-reduction model of depression using self-stimulating rats. an appraisal Pharmacol. Biochem. Behav. 10:1979;441-443.
6. Blier P., De Montigny C., Chaput Y. Modifications of the serotonergic system by antidepressant treatments. Implication for the therapeutic response in major depression J. Clin. Psychopharmacol. 7:1987;24S-35S.
7. Boyer W.F., Feighner J.P. Side-effects of the selective serotonin re-uptake inhibitors. Feighner J.P., Boyer W.F. Selective serotonin re-uptake inhibitors. 1991;133-152 John Wiley & Sons Ltd, New York.
8. Burrows G.D., McIntyre I., Judd F., Norman T.R. Clinical effects of serotonin inhibitors in the treatment of depressive illness. J. Clin. Psychiatry (Suppl.). 49:1988;18-22.
9. 2 receptors in chronic fluoxetine-treated rats. Eur. J. Pharmacol. 322:1997;123-127.
10. Coppen A. The biochemistry of affective disorders. Br. J. Psychiatry. 113:1967;1237-1264.
11. Fibiger H.C., Phillips A.G. Increased intracranial self-stimulation in rats after long-term administration of desipramine. Science. 214:1981;683-685.
12. Frazer A. Pharmacology of antidepressants. J. Clin. Psychopharmacol. (Suppl.). 17:1997;2S-18S.
13. Gallistel C.R. Self-stimulation in the rat. Quantitative characteristics of the reward pathway J. Comp. Physiol. Psychol. 92:1978;977-998.
14. 1A autoreceptors in the machanism of action of serotoninergic antidepressant drugs. Recent findings from in vivo microdialysis studies Fundam. Clin. Pharmacol. 10:1996;16-27.
15. Hall F.S., Stellar J.R., Kelley A.E. Acute and chronic desipramine treatment effects on rewarding electrical stimulation of the lateral hypothalamus. Pharmacol. Biochem. Behav. 37:1990;277-281.
16. Hammer R.P. Jr., Margulies J.E., Lynn A.B., Brady L.S. Chronic fluoxetine treatment upregulates dopamine receptors in the mesolimbic forebrain of the rat. Depression. 1:1993;82-87.
17. Harris T.H. Depression induced by Rauwolfia compounds. Am. J. Psychiatry. 113:1957;950-963.
18. 1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI). Behav. Brain Res. 73:1996;281-283.
19. Howell D.C. Statistical methods for psychology. 3rd ed:1992;Duxbury Press, Belmont.
20. Julien R.M. A primer of drug action. A concise, nontechnical guide to the actions, uses, and side effects of psychoactive drugs 8th ed:1998;W. H. Freeman and Company, New York.
21. Kent S., Bret-Dibat J.L., Kelley K.W., Dantzer R. Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci. Biobehav. Rev. 20:1996;171-175.
22. Kuhs H., Schlake H.-P., Rolf L.H., Rudolf G.A. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline. Acta Psychiatr. Scand. 85:1992;364-369.
23. Lane R., Baldwin D., Preskhorn S. The SSRIs. Advantages, disadvantages and differences J. Psychopharmacol. (Suppl.). 9:1995;163-178.
24. Lee K., Kornetsky C. Acute and chronic fluoxetine treatment decreases the sensitivity of rats to rewarding brain stimulation. Pharmacol. Biochem. Behav. 60:1998;539-544.
25. Maes M., Meltzer H.Y. The serotonin hypothesis of major depression. Bloom F.E., Kupfer D.J. Psychopharmacology. The fourth generation of progress:1995;933-944 Raven Press, New York.
26. Markou A., Hauger R.L., Koob G.F. Desmethylimipramine attenuates cocaine withdrawal in rats. Psychopharmacology (Berlin). 109:1992;305-314.
27. McCarter B.D., Kokkinidis L. The effects of long-term administration of antidepressant drugs on intracranial self-stimulation responding in rats. Pharmacol. Biochem. Behav. 31:1988;243-247.
28. Mobbs C.V., Rothfeld J.M., Saluja R., Pfaff D.W. Phorbol esters and forskolin infused into midbrain central gray facilitate lordosis. Pharmacol. Biochem. Behav. 34:1989;665-667.
29. Moreau J.L., Jenck F., Martin J.R., Mortas P., Haefely W.E. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur. Neuropsychopharmacol. 2:1992;43-49.
30. Mundl W.J. A constant-current stimulator. Physiol. Behav. 24:1980;991-993.
31. Nemeroff C.B. Paroxetine. An overview of the efficacy and safety of a new selective reuptake inhibitor in the treatment of depression J. Clin. Psychopharmacol. 13(Suppl. 2):1993;10S-17S.
32. Ottervanger J.P., Stricker B.H., Huls J., Weeda J.N. Bleeding attributed to the intake of paroxetine. Am. J. Psychiatry. 151:1994;781-782.
33. Pawson P.A., Preston E., Haas N., Foster D.O. Hypothalamic sites where electrical stimulation increases metabolic rate in the rat. Soc. Neurosci. Abstr. 13:1987;1163.
34. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd ed:1986;Academic Press, San Diego, CA.
35. Plata-Salaman C.R., Oomura Y., Kai Y. Tumor necrosis factor and interleukin-1 beta. Suppresion of food intake by direct action on the central nervous system Brain Res. 448:1988;106-114.
36. Sachar E.J., Baron M. The biology of affective disorders. Ann. Rev. Neurosci. 2:1979;505-518.
37. Schildkraut J.J. The catecholamine hypothesis of affective disorders. A review of supporting evidence Am. J. Psychiatry. 122:1965;509-520.
38. Simansky K.J. Serotonergic control of the organization of feeding and satiety. Behav. Brain Res. 73:1996;37-42.
39. Sonti G., Ilyin S.E., Plata-Salaman C.R. Neuropeptide Y blocks and reverses interleukin-1β-induced anorexia in rats. Peptides. 17:1996;517-520.
40. Stanley B.G., Chin A.S., Leibowitz S.F. Feeding and drinking elicited by central injection of neuropeptide Y. Evidence for a hypothalamic site(s) of action Brain Res. Bull. 14:1985;521-524.
41. Tasker T.C.G., Kaye C.M., Zussman B.D., Link C.G. Paroxetine plasma levels. Lack of correlation with efficacy or adverse events Acta Psychiatr. Scand. (Suppl.). 80:1989;152-155.
42. Tringali G., Mirtella A., Mancuso C., Guerriero G., Preziosi P., Navarra P. The release of immunoreactive interleukin-1β from rat hypothalamic explants is modulated by neurotransmitters and corticotropin-releasing hormone. Pharmacol. Res. 36:1997;269-273.
43. Valentino D.A., Riccitelli A.J., Dufresne R.L. Chronic DMI reduces thresholds for brain stimulation in the rat. Pharmacol. Biochem. Behav. 39:1991;1-4.
44. Zhu X.-O., McNaughton N. The interaction of serotonin depletion with anxiolytics and antidepressants on reticular-elicited hippocampal RSA. Neuropharmacology. 33:1994;1597-1605.